• Western blot analysis of lysates from COS7 cells, using VN1R4 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of the lysates from COLO205 cells using VN1R4 antibody.
  • Immunofluorescence analysis of MCF7 cells, using VN1R4 Antibody. The picture on the right is blocked with the synthesized peptide.

Anti-VN1R4 antibody (88-137 aa) (STJ96250)

SKU:
STJ96250

Current Stock:
Host: Rabbit
Applications: WB/IF/ELISA
Reactivity: Human/Monkey
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Vomeronasal type-1 receptor 4 (88-137 aa) is suitable for use in Western Blot, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IF 1:200-1:1000
ELISA 1:20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: VN1R4
Gene ID: 317703
Uniprot ID: VN1R4_HUMAN
Immunogen Region: 88-137 aa
Specificity: VN1R4 Polyclonal Antibody detects endogenous levels of VN1R4 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human VN1R4 at the amino acid range 88-137
Protein Name Vomeronasal Type-1 Receptor 4
G-Protein Coupled Receptor Gpcr27
Hgpcr27
V1r-Like Receptor 4
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Vomeronasal Type-1 Receptor 4 antibody
Anti-G-Protein Coupled Receptor Gpcr27 antibody
Anti-Hgpcr27 antibody
Anti-V1r-Like Receptor 4 antibody
Anti-VN1R4 antibody
Anti-V1RL4 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance